recombinant human nerve growth factor (Jiangsu Xintrum Pharmaceuticals)

N/A

Report date: 2025/03/20 10:02:07

Base Information

Drug Namerecombinant human nerve growth factor (Jiangsu Xintrum Pharmaceuticals)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionLow affinity neurotrophin receptor p75NTR agonists
TargetsLow affinity neurotrophin receptor p75NTR
Therapy Area/IndicationsTrauma, Nervous System
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXintrum Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXintrum Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsTrauma, Nervous System
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A